Wanda Health

Empowering Better Care Through Early Detection

About Us

Wanda Health is empowering providers with seven-day advanced detection of exacerbations in patients with chronic and acute conditions, helping them speed interventions and prevent adverse events from occurring.


Our predictive remote patient monitoring solution is the most effective option due to the integration of patient-generated health data, real-time artificial intelligence, and automated adherence features.


As a result of using Wanda Health, providers are experiencing better outcomes and quality scores, increased care plan adherence, improved patient satisfaction scores, increased revenue, and reduced cost of care for a range of chronic, acute, and specialty diseases and conditions including, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, Hypertension, Diabetes,


Wanda Health's usefulness was developed over eight clinical trials at the UCLA hospital system and Cedars Sinai, culminating in seven patents and one patent pending.  Based in Seattle, WA, Wanda Health is backed by NetScientific PLC, a London Stock Exchange-listed healthcare, technology, and investment group. Their portfolio leverages trans-Atlantic relationships and global opportunities to deliver shareholder value.

Company Leadership



Bill is the catalyst to the rapid adoption of Wanda Health by the healthcare industry.  His background of success in the C-suite includes international leadership in healthcare focused EHR, predictive analytics,  and software  companies including Complia Health, Deyta, Delta Health Technologies and OCS.  Early in his career, he headed marketing and sales for allied healthcare companies including the Sonicare Sonic Toothbrush. Bill is a recipient of multiple Gold Medals from the Medical Marketing Association, was named to the Marketing 100 in US. He has also appeared on the Oprah Winfrey Show. He serves as board member of Wanda Health.


Non Executive Director

Dr. Iliev is a Managing Director of EMV Capital, a London-based investor in B2B companies in the healthcare, transportation, energy and technology sectors. Previously he founded CambridgeIP, UK a boutique consultancy focused on IP commercialization working with clients in healthcare, energy and other sectors. Dr. Iliev is a Board Member of NetScientific PLC, a transatlantic healthcare IP commercialization group that funds and develops companies engaged to significantly improve the health and well-being of people with chronic diseases. He also serves on the Board of Directors of Sofant Technologies, Pointgrab, Q-Bot, Glycotest, Vortex Biosciences and Wanda Health.



Kevin is Adjunct Professor of Telehealth at the Maersk Institute, and is an advisor, founder, Chair and investor in digital health businesses involved in telecare, AI and digital imaging.

Kevin formerly was a Director of Genomics England, and headed Cisco’s innovation advisory team in Healthcare & Life Sciences.

A McIntosh.jpg

Director, Product Management

Andrew manages Wanda Health’s product strategy. He has over 20 years experience in the telehealth industry developing successful world class remote patient monitoring solutions. Formerly head of product at Tunstall Americas and telehealth product manager at Tunstall Healthcare UK, Andrew has a degree in electronic communication and is a member of the BCS Chartered Institute of IT.

Wanda Health in the News

Lake Chelan Health_Color.jpg
PCP 1st Logo (1).PNG

Telehealth Shown to be Successful in Supporting PCP1st During COVID-19 Pandemic

Wanda Blu-wbackground1.png
Wanda Blu-wbackground1.png
EMV Capital Logo Small.png

Improves Care - Saves Time - Adds Revenue

Improves Care - Saves Time - Adds Revenue

Wanda Health’s Advanced COVID-19 Telehealth Programs Chosen to Protect Patients in Michigan

Wanda Health’s Rapid Deployment Telehealth for COVID-19 Screening and Care Management Selected by FL and WA Providers

EMV Capital Announces Acquisition of Wanda, Inc


Improving Home-Centered Care

Advance HN.png

Improve Care Quality, Reduce Costs with Effective Analytics Use


Patient adherence: The greatest risk to any home-centered care program


Health Resource Solutions selects Wanda’s chronic disease management platform to advance care of individuals with CHF and COPD


Enhancing Home-centered Care with the Right Technologies


Wanda partners with Dignity Health to launch OncoVerse to deliver advanced oncology decision support


24Hr HomeCare to Deploy Wanda’s Home-Centered Care Technology to Improve Care and Reduce Readmissions


Can machine learning tackle the top killer of American women?


mHealth Platforms Are Proving Their Value to Home Health Agencies


Value-based care success requires patient adherence and the right technology – McKnight’s Long Term Care News

Wanda White backgroundTR1 Test 1.png

The challenges of managing the high cost of chronic disease

Improves Care - Saves Time - Adds Revenue

  • Increases patient understanding and engagement in their treatment plan

  • Faster time to interventions

  • Reduces unplanned emergent care and crisis management

  • Improves care coordination and productivity

  • Reduced unplanned hospitalizations and ED visits

  • Adds revenue from new reimbursable services

Get Predictive RPM for Your Patients!

5608 17th Ave NW, #1101

Seattle,  WA 98107 USA


Thanks for submitting!